Molecular design of anti-AIDS drugs targeting the human transcription machinery employed for the replication of AIDS virus

针对艾滋病病毒复制所用的人类转录机制的抗艾滋病药物的分子设计

基本信息

  • 批准号:
    12557219
  • 负责人:
  • 金额:
    $ 7.49万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2002
  • 项目状态:
    已结题

项目摘要

The Long Terminal Repeat, the promoter region of the AIDS provirus contains a tandem kB sequence, three consecutive GC boxes, and a TATA box. Proteins NFkB, HIV-EP1 and Sp1 specifically bind to these sequences and paticipate in the transcription amf replicatiom of AIDS virus. The present research aimed at proteins and nucleic acids, i. e., the inhibition of the functions of these transcriptional proteins and the design of DNA-cleaving agents targeting the Long Terminal RepeatSp1 and HIV-EP1 is a zinc finger proteins containing zinc in their DNA recognition-binding sites. We prepared various pyridine-based zinc chelators to inactivate these proteims by abstracting zinc. We synthesized biphenyl-type metal chelators with an aromatic substituent on the pyridine, considering the enzyme binding. In particular, a compound with a naphthyl group showed excellent inhibitory activity against a zinc protein.We carried out a molecular design of novel peptide nucleic acid for the specific recognition of the DNA sequence of HIV provirus. We prepared optically active monomer constituents and the corresponding oligomer of peptide nucleic acids containing a glycyl-b-alanine backbone starting with D-and L-aspartic acids.Thus, the results of the present research include the successful design of novel metal chelators that inhibit the function of zinc proteins and development of a novel peptide nucleic acid that could target the DNA of AIDS provirus.
艾滋病前病毒的启动子区长末端重复序列包含一个串联的kB序列、三个连续的GC盒和一个TATA盒。NFkB、HIV-EP 1和Sp1蛋白与这些序列特异性结合,参与AIDS病毒的转录和复制。目前的研究主要针对蛋白质和核酸,即蛋白质和核酸。例如,抑制这些转录蛋白的功能和设计靶向长末端重复序列Sp1和HIV-EP 1的DNA切割剂是在其DNA切割结合位点含有锌的锌指蛋白。我们制备了各种吡啶基锌螯合剂,通过提取锌来固定这些蛋白质。考虑到酶的结合作用,我们合成了吡啶上带有芳香取代基的联苯型金属螯合剂。特别地,具有萘基的化合物对锌蛋白表现出优异的抑制活性。我们进行了一种新的肽核酸的分子设计,用于特异性识别HIV前病毒的DNA序列。我们制备了以D-和L-天冬氨酸为起始原料的含有甘氨酰-b-丙氨酸骨架的肽核酸的光学活性单体组分和相应的寡聚体,因此,本研究的结果包括成功设计了抑制锌蛋白功能的新型金属螯合剂和开发了能够靶向AIDS前病毒DNA的新型肽核酸。

项目成果

期刊论文数量(42)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Rakesh Kumar Sharma: "Aurine tricarboxylic acid, a potential metal-chelating inhibitor of NFkB-DNA binding"Bioorg.Med.Chem.. 8. 1819-1823 (2000)
Rakesh Kumar Sharma:“金三羧酸,NFkB-DNA 结合的潜在金属螯合抑制剂”Bioorg.Med.Chem.. 8. 1819-1823 (2000)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hitoshi Takatsuna: "Identification of TIFA as an Adapter Protein that Links TRAP6 to IRAK-1 in IL-1 Receptor Signaling"J. Bio. Chem.. in press (2003)
Hitoshi Takatsuna:“鉴定 TIFA 作为 IL-1 受体信号传导中将 TRAP6 与 IRAK-1 连接的衔接蛋白”J。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Akiyuki Hamasaki: "A Novel Metal-Chelating Inhibitor of Protein Farnesytransferase"Bioorg. Med. Chem. Lett.. in press (2003)
Akiyuki Hamasaki:“蛋白质法尼基转移酶的新型金属螯合抑制剂”Bioorg。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yasuharu Hori: "Sensitization of Hyperthermic Treatment of Leukemic Cell Lines by a Synthetic Peptide"Bioorg. Med Chem.. Vol.10. 111-115 (2002)
Yasuharu Hori:“合成肽对白血病细胞系的热疗的敏感性”Bioorg。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Mohamed Abdel-Aziz: "Synthesis and Hibridization Property of Novel 2,5'-Iso-DNA Mimic Chiral Peptide Nudeic Acids"Bioorg. Med. Chem. Lett.. in press (2003)
Mohamed Abdel-Aziz:“新型 2,5-Iso-DNA 模拟手性肽核酸的合成和杂交特性”Bioorg。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OTSUKA Masami其他文献

OTSUKA Masami的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OTSUKA Masami', 18)}}的其他基金

Design and synthesis of anti-brain tumor and brain-protective drugs using brain-targeting peptides
脑靶向肽设计与合成抗脑肿瘤和脑保护药物
  • 批准号:
    24659048
  • 财政年份:
    2012
  • 资助金额:
    $ 7.49万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of medicinal molecules having biologically functions targeting the PI3K/Akt pathway and the TGF-b/Smad pathway
开发具有针对PI3K/Akt途径和TGF-b/Smad途径的生物学功能的药物分子
  • 批准号:
    23390028
  • 财政年份:
    2011
  • 资助金额:
    $ 7.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Design and synthesis of anti-HIV agents that inhibit the Vif-mediated proteasome degradation of APOBEC3G
设计和合成抑制 Vif 介导的 APOBEC3G 蛋白酶体降解的抗 HIV 药物
  • 批准号:
    22659024
  • 财政年份:
    2010
  • 资助金额:
    $ 7.49万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Design of DNA-cleaving and -crosslinking agents based on NFκB and HMGA proteins aiming at the application to cancer therapy
基于 NFκB 和 HMGA 的 DNA 切割和交联剂设计,针对蛋白质在癌症治疗中的应用
  • 批准号:
    20390033
  • 财政年份:
    2008
  • 资助金额:
    $ 7.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of zinc chelators with protein specificity aiming at molecular target therapy of cancer
开发针对癌症分子靶向治疗的蛋白质特异性锌螯合剂
  • 批准号:
    17390030
  • 财政年份:
    2005
  • 资助金额:
    $ 7.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular design of anti-AIDS drugs targeting the viral and host zinc proteins
针对病毒和宿主锌蛋白的抗艾滋病药物的分子设计
  • 批准号:
    15390038
  • 财政年份:
    2003
  • 资助金额:
    $ 7.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular Design of Ras Farnesyltransferase Inhibitors
Ras 法尼基转移酶抑制剂的分子设计
  • 批准号:
    11694297
  • 财政年份:
    1999
  • 资助金额:
    $ 7.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of compounds for multiple regulation of intracellular signaling
开发用于细胞内信号传导多重调节的化合物
  • 批准号:
    11470496
  • 财政年份:
    1999
  • 资助金额:
    $ 7.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Molecular design and synthesis of anti-cancer compounds that cause apoptosis
引起细胞凋亡的抗癌化合物的分子设计和合成
  • 批准号:
    09672280
  • 财政年份:
    1997
  • 资助金额:
    $ 7.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Identification of novel, interferon-inducible anti-AIDS virus host factors
新型干扰素诱导抗艾滋病病毒宿主因子的鉴定
  • 批准号:
    17K15701
  • 财政年份:
    2017
  • 资助金额:
    $ 7.49万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Investigation of the molecular mechanism of AIDS virus evolution
艾滋病病毒进化的分子机制研究
  • 批准号:
    15K07166
  • 财政年份:
    2015
  • 资助金额:
    $ 7.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Introducing restriction factors into the genome of an AIDS virus host species
将限制因子引入艾滋病病毒宿主物种的基因组中
  • 批准号:
    9025396
  • 财政年份:
    2015
  • 资助金额:
    $ 7.49万
  • 项目类别:
Studies of the precursor of the human AIDS virus in its natural chimpanzee host
对黑猩猩天然宿主中人类艾滋病病毒前体的研究
  • 批准号:
    9186500
  • 财政年份:
    2015
  • 资助金额:
    $ 7.49万
  • 项目类别:
Studies to search for the process from the birth of AIDS virus in the heart of African continent to its pandemic transmission route to the whole world
研究探寻艾滋病病毒从非洲大陆中心诞生到全球大流行传播途径的过程
  • 批准号:
    26257505
  • 财政年份:
    2014
  • 资助金额:
    $ 7.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Can vaccine-induced CD8 T cells prevent chronic phase AIDS virus replication?
疫苗诱导的 CD8 T 细胞能否阻止慢性期艾滋病病毒复制?
  • 批准号:
    8787712
  • 财政年份:
    2014
  • 资助金额:
    $ 7.49万
  • 项目类别:
Can vaccine-induced CD8 T cells prevent chronic phase AIDS virus replication?
疫苗诱导的 CD8 T 细胞能否阻止慢性期艾滋病病毒复制?
  • 批准号:
    8976140
  • 财政年份:
    2014
  • 资助金额:
    $ 7.49万
  • 项目类别:
Mechanism analysis of lasting of AIDS virus control with SIV controllers.
SIV控制剂持久控制艾滋病病毒的机制分析。
  • 批准号:
    25893294
  • 财政年份:
    2013
  • 资助金额:
    $ 7.49万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Introducing restriction factors into the genome of an AIDS virus host species
将限制因子引入艾滋病病毒宿主物种的基因组中
  • 批准号:
    8645612
  • 财政年份:
    2012
  • 资助金额:
    $ 7.49万
  • 项目类别:
Introducing restriction factors into the genome of an AIDS virus host species
将限制因子引入艾滋病病毒宿主物种的基因组中
  • 批准号:
    8464631
  • 财政年份:
    2012
  • 资助金额:
    $ 7.49万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了